Recent studies have shown that ME1 contributes to the progression of several cancers, such as oral squamous cell carcinoma,25 breast cancer,26 colorectal cancer,27 gastric cancer,28, 29 lung cancer,30 and nasopharyngeal carcinoma.31 Here, ME1 is linked to nasopharyngeal carcinoma.